Transmission of Burkholderia cepacia complex: Evidence for new epidemic clones infecting cystic fibrosis patients in Italy

Journal of Clinical Microbiology

Volumn 43, Issue 10, 2005, Pages 5136-5142

  Campana, S ^a,t   Taccetti, G ^a   Ravenni, N ^a   Favari, F ^d   Cariani, L ^d   Sciacca, A ^e   Savoia, D ^f   Collura, A ^g   Fiscarelli, E ^h   De Intinis, G ⁱ   Busetti, M ^j   Cipolloni, A ^k   D'Aprile, A ^l   Provenzano, E ^m   Collebrusco, I ⁿ   Frontini, P ^o   Stassi, G ^p   Trancassini, M ^q   Tovagliari, D ^r   Lavitola, A ^s   Doherty, C J ^c   Coenye, T ^b   Govan, J R W ^c   Vandamme, P ^b   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g Ospedale dei Bambini G Di Cristina   (Italy)

^h BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

ⁱ SANT ANNA HOSPITAL   (Italy)

^j Istituto di Igiene   (Italy)

^k BUFALINI HOSPITAL   (Italy)

^l Ospedale G Tatarella   (Italy)

^m Ospedale di Soverato   (Italy)

ⁿ Ospedale Calai   (Italy)

^o Ospedale Pediatrico G Salesi   (Italy)

^p UNIVERSITY OF MESSINA   (Italy)

^q SAPIENZA UNIVERSITY OF ROME   (Italy)

^r UNIVERSITY OF PARMA   (Italy)

^s UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^t UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN;

ACHROMOBACTER XYLOSOXIDANS; ARTICLE; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BURKHOLDERIA; BURKHOLDERIA AMBIFARIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA GLADIOLI; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA PYRROCINIA; BURKHOLDERIA STABILIS; BURKHOLDERIA VIETNAMIENSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; EPIDEMIC; HERBASPIRILLUM; HUMAN; INQUILINUS LIMOSUS; ITALY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PSEUDOMONAS; PULSED FIELD GEL ELECTROPHORESIS; RECA GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECIES IDENTIFICATION; STENOTROPHOMONAS MALTOPHILIA;

BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CLONE CELLS; CYSTIC FIBROSIS; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; ITALY; POLYMERASE CHAIN REACTION; PREVALENCE; SPUTUM;

ACHROMOBACTER XYLOSOXIDANS; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA AMBIFARIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA GLADIOLI; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA PYRROCINIA; BURKHOLDERIA STABILIS; BURKHOLDERIA VIETNAMIENSIS; HERBASPIRILLUM; INQUILINUS LIMOSUS; PSEUDOMONAS; STENOTROPHOMONAS MALTOPHILIA;

EID: 26944456962     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.10.5136-5142.2005     Document Type: Article

References (69)

1. Agodi, A., E. Mahenthiralingam, M. Barchitta, V. Giannino, A. Sciacca, and S. Stefani. 2001. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J. Clin. Microbiol. 39:2891-2896.
2. Bevivino, A., C. Dalmastri, S. Tabacchioni, L. Chiarini, M. L. Belli, S. Piana, A. Materazzo, P. Vandamme, and G. Manno. 2002. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J. Clin. Microbiol. 40:846-851.
3. Biddick, R., T. Spilker, A. Martin, and J. J. LiPuma. 2003. Evidence of transmission of Burkhcldena cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett. s228:57-62.
4. Brisse, S., C. Cordevant, P. Vandamme, P. Bidet, C. Loukil, G. Chabanon, M. Lange, and E. Bingen. 2004. Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis. J. Clin. Microbiol. 42:4824-4827.
5. Butler, S., C. J. Doherty, J. E. Hughes, J. W. Nelson, and J. R. W. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004.
6. Campana, S., G. Taccetti, N. Ravenni, F. Favari, L. Cariani, A. Sciacca, O. Bianco, T. Pensabene, E. Fiscarelli, G. De Intinis, M. Busetti, A. Cipolloni, A. d'Aprile, F. Giofirè, I. Collebrusco, P. Frontini, G. Stassi, A. Magni, D. Tovagliari, A. Lavitola, C. J. Doherty, J. R. W. Govan, and P. Vandamme. 2003. Transmission of Burkholderia pyrrocinia: a report of two outbreaks between Italian cystic fibrosis patients. Pediatr. Pulmonol. 25 (Suppl.):299.
7. Chaparro, C., J. Maurer, M. Gutierrez, M. Krajden, T. Chan, S. Winston, S. Keshavjee, M. Scavuzzo, E. Tullis, M. Hutcheon, and S. Kesten. 2001. Infection with Burkholderia cepacia in cystic fibrosis. Outcome following lung transplantation. Am. J. Respir. Care Med. 163:43-48.
8. Chen, J. S., K. Witzmann, T. Spilker, R. Fink, and J. J. LiPuma. 2001. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 139:643-649.
9. Clode, F. E., M. E. Kaufmann, H. Malnik, and T. L. Pitt. 2000. Distribution of genes encoding putative transmissibility factors among epidemic and non-epidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J. Clin. Microbiol. 38:1763-1766.
10. Coenye, T., E. Mahenthiralingam, D. Henry, J. J. LiPuma, S. Laevens, M. Gillis, D. P. Speert, and P. Vandamme. 2001. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex comprising biocontrol and cystic-fibrosis related isolates. Int. J. Syst. Evol. Microbiol. 51:1481-1490.
11. Coenye, T., P. Vandamme, J. R. W. Govan, and J. J. LiPuma. 2001. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 39:3427-3436.
12. Coenye, T., T. Spilker, A. Martin, and J. J. LiPuma. 2002. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J. Clin. Microbiol. 40:3300-3307.
13. Coenye, T., J. Goris, T. Spilker, P. Vandamme, and J. J. LiPuma. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J. Clin. Microbiol. 40:2052-2069.
14. Coenye, T., and J. J. LiPuma. 2003. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 149:77-88.
15. Coenye, T., and J. J. LiPuma. 2003. Molecular epidemiology of Burkholderia species. Front. Biosci. 8:e55-e67.
16. Coenye, T., T. Spilker, A. Van Schoor, J. J. LiPuma, and P. Vandamme. 2004. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax 59:952-954.
17. Cunha, M. V., J. H. Leitao, E. Mahenthiralingam, P. Vandamme, L. Lite, C. Barreto, M. J. Salgado, and I. Sa-Correia. 2003. Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J. Clin. Microbiol. 41:4113-4120.
18. De Boeck, K., A. Malfroot, L. Van Schil, P. Lebecque, C. Knoop, J. R. Govan, C. Doherty, S. Laevens, P. Vandamme, et al. 2004. Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients. Eur. Respir. J. 23:851-856.
19. De Soyza, A., K. Morris, A. McDowell, C. Doherty, L. Archer, J. Perry, J. R. W. Govan, P. A. Corris, and K. Gould. 2004. Prevalence and clonality in UK patients with cystic fibrosis referred for lung transplantation. Thorax 59:526-528.
20. Dinesh, S. D., H. Grundmann, T. L. Pitt, and U. Römling. 2003. Europeanwide distribution of Pseudomonas aeruginosa clone C. Clin. Microbiol. Infect. 9:1228-1233.
21. Drevinek, P., O. Cinek, J. Melter, L. Langsadl, Y. Navesnakova, and V. Vavrova. 2003. Genomovar distribution of the Burkholderia cepacia complex differs significantly between Czech and Slovak patients with cystic fibrosis. J. Med. Microbiol. 52:603-604.
22. Festini, F., S. Ballarin, C. Loganes, T. Codamo, R. Doro, A. Adamo, R. Adorni, M. Cucci, F. Di Marco, R. Lovallo, S. Omenetti, R. Panebianco, G. Pisano, A. Russo, M. C. Sciabacucchi, and M. L. Zunino. 2004. Prevention and control of respiratory tract infections in the network of Italian Centers for Cystic Fibrosis. Assist. Inferm. Ric. 23:14-20. (In Italian.)
23. Goris, J., W. Dejonghe, E. Falsen, E. De Clerck, B. Geeraerts, A. Willems, E. M. Top, P. Vandamme, and P. De Vos. 2002. Diversity of transconjugants that acquired plasmid pJP4 and pEMT1 after inoculation of a donor strain in the A- and B-horizon of an agricultural soil and description of Burkholderia hospita sp. nov. and Burkholderia terricola sp. nov. Syst. Appl. Microbiol. 25:340-352.
24. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
25. Govan, J. R. W., P. H. Brown, J. Maddison, C. Doherty, C. J. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis patients. Lancet 342:15-19.
26. Govan, J. R. W., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
27. Govan, J. R. W., J. Balandreau, and P. Vandamme. 2000. Burkholderia cepacia-friend and foe. ASM News 66:124-125.
28. Heath, D. G., K. Hohneker, C. Carriker, K. Smith, J. Routh, J. J. LiPuma, R. M. Aris, D. Wber, and P. H. Gilligan. 2002. Six-year molecular analysis of Burkholderia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J. Clin. Microbiol. 40:1188-1193.
29. Isles, A., M. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levinson. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
30. Johnson, W. M., S. D. Tyler, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32: 924-930.
31. Kidd, T. J., S. C. Bell, and C. Coulter. 2003. Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit. Eur. J. Clin. Microbiol. Infect. Dis. 22:434-437.
32. Koeuth, T., J. Versalovic, and J. R. Lupski. 1995. Differential subsequence conservation of interspersed repetitive Streptococcus pneumoniae BOX elements in diverse bacteria. Genome Res. 5:408-418.
33. Liou, T. G., F. R. Adler, S. C. FitzSimmons, B. C. Cahill, J. R. Hibbs, and B. C. Marshall. 2001. Predictive 5-years survivorship model of cystic fibrosis. Am. J. Epidemiol. 153:345-352.
34. LiPuma, J. J., S. E. Dasen, D. W. Nielson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094-1096.
35. LiPuma, J. J., A. Marks-Austin, D. S. Holsclaw, B. Winnie, P. H. Gilligan, and T. S. Stull. 1994. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr. Infect. Dis. 13:716-719.
36. LiPuma, J. J. 1998. Burkholderia cepacia: management issues and new insights. Clin. Chest Med. 19:473-486.
37. LiPuma, J. J. 1998. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr. Opin. Pulm. Med. 4:337-441.
38. LiPuma, J. J., T. Spilker, L. H. Gill, P. W. Campbell III, L. Liu, and E. Mahenthiralingam. 2001. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 164:92-96.
39. LiPuma, J. J., T. Spilker, T. Coenye, and C. F. Gonzales. 2002. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359:2002-2003.
40. Liu, L., T. Spilker, T. Coenye, and J. J. LiPuma. 2003. Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J. Clin. Microbiol. 41: 2471-2476.
41. Louws, F. J., D. W. Fulbright, C. T. Stephens, and F. J. de Bruyn. 1994. Specific genomic fingerprints of phytopathogenic Xanthomonas and Pseudomonas pathovars and strains generated with repetitive sequences and PCR. Appl. Environ. Microbiol. 60:2286-2295.
42. Magalhães, M., C. Doherty, J. R. W. Govan, and P. Vandamme. 2003. Polyclonal outbreak of Burkholderia cepacia complex bacteremia in haemodialysis patients. J. Hosp. Infect. 54:120-123.
43. Mahenthiralingam, E., J. Bischof, S. K. Byrne, C. Radomski, J. E. Davies, V. Av-Gay, and P. Vandamme. 2000. DNA-based approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38:3165-3173.
44. Manno, G., C. Dalmastri, S. Tabacchioni, P. Vandamme, R. Lorini, L. Minicucci, L. Romano, A. Giannattasio, L. Chiarini, and A. Bevivino. 2004. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian cystic fibrosis center. J. Clin. Microbiol. 42:1491-1497.
45. McMenamin, J. D., T. M. Zaccone, T. Coenye, P. Vandamme, and J. J. LiPuma. 2000. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: an analysis of 1051 recent sputum isolates. Chest 117:1661-1665.
46. Millar-Jones, L., H. C. Ryley, A. Paull, and M. C. Goodchild. 1998. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients. Respir. Med. 92:178-183.
47. Olive, D. M., and P. Bean. 1999. Principles and applications of methods for DNA-based typing of microbial organisms. J. Clin. Microbiol. 37:1661-1669.
48. Pegues, D. A., L. A. Carson, O. C. Tablan, S. C. FitzSimmons, S. B. Roman, J. M. Miller, and W. R. Jarvis. 1994. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J. Pediatr. 124:694-702.
49. Petrucca, A., P. Cipriani, P. Valenti, D. Santapaola, C. Cimmino, G. L. Scoarughi, L. Santino, S. Stefani, R. Sessa, and M. Nicoletti. 2003. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Res. Microbiol. 154:491-498.
50. Pitt, T. L., M. E. Kaufmann, P. S. Patel, L. C. Gaskin, and D. M. Livermore. 1996. Type characterization and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44:203-210.
51. Pot, B., P. Vandamme, and K. Kersters. 1994. Analysis of electrophoretic whole-organism protein fingerprints, p. 493-521. In M. Goodfellow and A. G. O'Donnel (ed.), Modern microbial methods. Chemical methods in prokaryotics systematics. J. Wiley and Sons, Ltd., Chichester, United Kingdom.
52. Rademaker, J. L. W., F. J. Louws, and F. J. de Bruijn. 1998. Characterization of the diversity of ecologically important microbes by rep-PCR fingerprinting, p. 1-26. In A. D. L. Akkermans, J. D. van Elsas, and F. J. de Bruijn (ed.), Molecular microbial ecology manual, supplement 3. Kluwer Academic Publishers, Dordrecht, The Netherlands.
53. 52a. Registro Italiano Fibrosi Cistica. 2002. Annual Report. Registre Italiano Fibrosi Cistica, Milan, Italy. (In Italian.)
54. Reik, R., T. Spilker, J. J. LiPuma. 2005. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J. Clin. Microbiol. 43:2926-2928.
55. Saiman, L., and J. Siegel. 2004. Infection control in cystic fibrosis. Clin. Microbiol. Rev. 17:57-71.
56. Schlichting, C., C. Branger, J. M. Fournier, W. Witte, A. Boutonnier, C. Wolz, P. Goullet, and G. During. 1993. Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J. Clin. Microbiol. 31:227-232.
57. Segonds, C., T. Heulin, N. Marty, and G. Chabanon. 1999. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J. Clin. Microbiol. 37:2201-2208.
58. Shreve, M. R., S. Butler, H. J. Kaplowitz, H. R. Rabin, D. Stokes, M. Light, and W. E. Regelmann for North American Scientific Advisory group and Investigators for the Epidemiologic Study of Cystic Fibrosis. 1999. Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis. J. Clin. Microbiol. 37:753-757.
59. Speert, D. P., D. Henry, P. Vandamme, M. Corey, and E. Mahenthiralingam. 2002. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis in Canada: geographical distribution and clustering of strains. Emerg. Infect. Dis. 8:181-187.
60. Sun, L., R. Z. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, U. Sajjan, Y. Tan, M. Riley, and R. Goldstein. 1995. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat. Med. 1:661-666.
61. Taccetti, G., and S. Campana. 1997. Microbiologic data overview of Italian cystic fibrosis patients. Eur. J. Epidemiol. 13:323-327.
62. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. A. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
63. Turton, J. F., M. E. Kaufmann, N. Mustafa, S. Kawa, F. E. Clode, and T. L. Pitt. 2003. Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom. J. Clin. Microbiol. 41:5750-5754.
64. UK Cystic Fibrosis Trust Infection Control Group. 2004. The Burkholderia cepacia complex. Suggestions for prevention and infection control. Cystic Fibrosis Trust, Bromley, Kent, United Kingdom.
65. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.
66. Vandamme, P., E. Mahenthiralingam, B. Holmes, T. Coenye, B. Hoste, P. De Vos, D. Henry, and D. P. Speert. 2000. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J. Clin. Microbiol. 38:1042-1047.
67. Vandamme, P., B. Holmes, T. Coenye, J. Goris, E. Mahenthiralingam, J. J. LiPuma, and J. R. W. Govan. 2003. Burkholderia cenocepacia sp. nov.-a new twist to an old story. Res. Microbiol. 154:91-96.
68. Vermis, K., T. Coenye, J. J. LiPuma, E. Mahenthiralingam, H. J. Nelis, and P. Vandamme. 2004. Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int. J. Syst. Evol. Microbiol. 54: 689-691.
69. Whiteford, M. L., J. D. Wilkinson, J. H. McColl, F. M. Conlon, J. R. Michie, T. J. Evans, and J. Y. Paton. 1995. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50:1194-1208.